These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 26327683)
1. Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease. Zekonyte J; Sakai K; Nicoll JA; Weller RO; Carare RO Biochim Biophys Acta; 2016 May; 1862(5):1047-53. PubMed ID: 26327683 [TBL] [Abstract][Full Text] [Related]
2. ApoE4 Astrocytes Secrete Basement Membranes Rich in Fibronectin and Poor in Laminin Compared to ApoE3 Astrocytes. Keable A; O'Neill R; MacGregor Sharp M; Gatherer M; Yuen HM; Johnston DA; Weller RO; Carare RO Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575521 [TBL] [Abstract][Full Text] [Related]
3. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Keable A; Fenna K; Yuen HM; Johnston DA; Smyth NR; Smith C; Al-Shahi Salman R; Samarasekera N; Nicoll JA; Attems J; Kalaria RN; Weller RO; Carare RO Biochim Biophys Acta; 2016 May; 1862(5):1037-46. PubMed ID: 26327684 [TBL] [Abstract][Full Text] [Related]
4. Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele. Hawkes CA; Sullivan PM; Hands S; Weller RO; Nicoll JA; Carare RO PLoS One; 2012; 7(7):e41636. PubMed ID: 22848551 [TBL] [Abstract][Full Text] [Related]
5. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Weller RO; Subash M; Preston SD; Mazanti I; Carare RO Brain Pathol; 2008 Apr; 18(2):253-66. PubMed ID: 18363936 [TBL] [Abstract][Full Text] [Related]
6. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340 [TBL] [Abstract][Full Text] [Related]
7. Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy. Hawkes CA; Jayakody N; Johnston DA; Bechmann I; Carare RO Brain Pathol; 2014 Jul; 24(4):396-403. PubMed ID: 24946077 [TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice. Xu F; Vitek MP; Colton CA; Previti ML; Gharkholonarehe N; Davis J; Van Nostrand WE J Neurosci; 2008 May; 28(20):5312-20. PubMed ID: 18480287 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide. Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439 [TBL] [Abstract][Full Text] [Related]
10. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146 [TBL] [Abstract][Full Text] [Related]
11. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging. Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682 [TBL] [Abstract][Full Text] [Related]
12. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429 [TBL] [Abstract][Full Text] [Related]
13. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease. Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538 [TBL] [Abstract][Full Text] [Related]
14. The nucleation growth and reversibility of Amyloid-beta deposition in vivo. Dolev I; Michaelson DM J Alzheimers Dis; 2006 Nov; 10(2-3):291-301. PubMed ID: 17119294 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease. Hartman RE; Laurer H; Longhi L; Bales KR; Paul SM; McIntosh TK; Holtzman DM J Neurosci; 2002 Dec; 22(23):10083-7. PubMed ID: 12451108 [TBL] [Abstract][Full Text] [Related]
16. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669 [TBL] [Abstract][Full Text] [Related]
17. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Weller RO; Boche D; Nicoll JA Acta Neuropathol; 2009 Jul; 118(1):87-102. PubMed ID: 19234858 [TBL] [Abstract][Full Text] [Related]